Article
Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness
22 Jul 2022
Abstract excerpt
Cancer progression is characterized and driven by gradual loss of a differentiated phenotype and gain of stem cell-like features. In prostate cancer (PCa), androgen receptor (AR) signaling is important for cancer growth, progression, and emergence of therapy resistance. Targeting the AR signaling axis has been, over the decades, the mainstay of PCa therapy. However, AR signaling at the transcription level is...
Topics
Join the communities discussing this publication.